PH:NYSEParker-Hannifin Corporation Analysis
Data as of 2026-03-09 - not real-time
$932.17
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Parker‑Hannifin is trading at $932.17, well above its DCF‑derived fair value of $324 and a forward P/E of 27.4 versus an industry average of 29.5, suggesting the market has priced in strong growth expectations. The stock sits below its 20‑day ($993) and 50‑day ($954) SMAs but remains above the 200‑day SMA ($804), while a 14‑day RSI of 36.9 points to near‑oversold conditions and a bearish MACD histogram of –12.36 reinforces short‑term downside pressure. Volume is increasing, and the price is holding just above the $900 support level, giving the near‑term a modest risk‑reward profile.
Fundamentally, PH delivered 9.1% revenue growth, 37% gross margin and a 25.8% ROE, with a low payout ratio of 26% and a dividend yield of 0.78%, indicating dividend sustainability. Recent analyst upgrades—Truist lifting its target to $1,139 and Baird to $1,050—highlight confidence in aerospace strength and margin expansion, while inclusion in top HVAC stock lists underscores sector diversification. These factors support a medium‑term buy outlook despite an elevated valuation.
Fundamentally, PH delivered 9.1% revenue growth, 37% gross margin and a 25.8% ROE, with a low payout ratio of 26% and a dividend yield of 0.78%, indicating dividend sustainability. Recent analyst upgrades—Truist lifting its target to $1,139 and Baird to $1,050—highlight confidence in aerospace strength and margin expansion, while inclusion in top HVAC stock lists underscores sector diversification. These factors support a medium‑term buy outlook despite an elevated valuation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI near oversold level
- Bearish MACD histogram
- Price testing $900 support
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst price‑target upgrades (Truist $1,139, Baird $1,050)
- Strong aerospace segment growth
- Margin expansion and solid cash flow
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Sustainable dividend with low payout ratio
- Durable industrial moat and diversified geography
- Valuation premium relative to DCF and peers
Key Metrics & Analysis
Financial Health
Revenue Growth9.10%
Profit Margin17.29%
P/E Ratio34.0
ROE25.78%
ROA9.44%
Debt/Equity68.92
P/B Ratio8.2
Op. Cash Flow$3.7B
Free Cash Flow$2.5B
Industry P/E29.5
Technical Analysis
TrendBullish
RSI37.0
Support$900.00
Resistance$1,034.96
MA 20$993.47
MA 50$953.83
MA 200$804.42
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Fair Value$324.38
Target Price$1,031.39
Upside/Downside10.64%
GradeOvervalued
TypeGrowth
Dividend Yield0.78%
Risk Assessment
Beta1.26
Volatility24.71%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.